Post-Grant Review: the good, the bad and the ugly for biotechnology companies

Citation metadata

Date: Jan. 2012
From: Journal of Commercial Biotechnology(Vol. 18, Issue 1)
Publisher: thinkBiotech LLC
Document Type: Report
Length: 1,625 words
Lexile Measure: 1860L

Document controls

Main content

Abstract :

This paper summarizes the Post-Grant Review process, one of the many interesting aspects of patent reform brought about by the enactment of the America Invents Act, and the effect it may have on how Biotechnology companies conduct business and manage their intellectual property. The content of this paper is intended to only provide a general guide to the subject matter. The views expressed in this paper are the personal views of the authors. Journal of Commercial Biotechnology (2012) 97-99. doi: 10.5912/jcb.499

Source Citation

Source Citation   

Gale Document Number: GALE|A312175233